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Abstract  
 
Information technology (IT)  has emerged as a central to the solution of contemporary genomics 
and drug discovery problems. Researchers involved in genomics, proteomics, transcriptional 
profiling, high throughput structure determination, and in other sub-disciplines of bioinformatics 
have direct impact on this IT revolution. As the full genome sequences of many species, data 
from structural genomics, micro-arrays, and proteomics became available, integration of these 
data to a common platform require sophisticated bioinformatics tools. Organizing these data into 
knowledgeable databases and developing appropriate software tools for analyzing the same are 
going to be major challenges. XML (eXtensible Markup Language) forms the backbone of 
biological data representation and exchange over the internet, enabling researchers to aggregate 
data from various heterogeneous data resources. The present article covers a comprehensive idea 
of the integration of  XML on  particular type of biological databases mainly dealing with 
sequence-structure-function relationship and its application towards drug discovery. This           
e-medical science approach should be applied to other scientific domains and the latest trend in 
semantic web applications is also highlighted.  
 
Introduction 
 
The term informatics is widely playing an important role in different disciplines of scientific 
arena. Some of the well known informatics area in biomedical science include bioinformatics, 
structural bioinformatics, chemoinformatics, pharmacoinformatics, medical informatics, 
immunoinformatics, genome informatics, microarray informatics, neuroinformatics, biodiversity 
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informatics,  biomolecular informatics, clinical informatics, and pharmacy informatics. It  is well 
known that the size of the human genome has an estimated 30,000 to 40,000 genes, and it would 
be interesting to consider just how many structural targets this tsunami of data represents. A 
complete assessment of the number of structural genomics targets for therapeutic intervention is 
important for the development of post-genomic research era within the pharmaceutical industry. 
It is well known that an understanding of the molecular structure leads to knowledge of 
molecular mechanism of action and its function.  Molecular structural knowledge is therefore 
vital if we have to proceed to a complete understanding of life at the atomic level. Molecular 
information in biological systems  are mainly restricted to four type of macromolecules i.e. 
proteins, nucleic acids, polysaccharides and lipids for interacting among themselves and with 
small molecules or drugs. The affinity, specificity, toxicity and inability to obtain lead molecules 
for nucleic acids, polysaccharides and lipids suggest that proteins are the main source for drug 
targets. 
 
Genomic sequence to structure prediction is one of the most challenging tasks in computational 
structural biology program. Some well known protein structure prediction techniques are de-
novo or ab-initio modeling and comparative protein modeling which again is divided into 
homology modeling and protein threading. On the basis of primary sequence information of a 
given protein different methods have been developed in predicting structure: Prediction of 
secondary structure (beta sheets, α-helix, coils) from primary sequence, ab-initio structure 
prediction, homology modeling – up to X-ray crystallography model accuracy i.e. 2-3 Å and 
protein threading (fold family recognition). 
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Homology modeling uses the fact that  if sequence of the unknown protein with ≥30% sequence 
similarity is found with the target protein whose three dimensional structure is known, it is 
appropriate to assume that the two proteins have similar tertiary folds. This method is useful to a) 
hypothetically predict functional regions of  proteins, b) design or interpret site-directed 
mutagenesis experiments, c) spectral properties, d) protein structure-based drug design and d) 
docking analysis e) functional assignment for genomic data. Its limitations are a) structural 
differences occurring  in surface loops of  the  protein and  b) theoretically predicted low 
resolution structures. Protein threading i.e fold family recognition method classifies known 
structures into families with similar foldings. Given a sequence of amino acids, we can select the 
family to which the given sequence most likely belongs. 
 
Discussion and Applications 
Bio-Chemo-Pharmaco-informatics disciplines holds out strong expectations of reducing the time 
and cost of development in pharmaceutical industries from genome to drug by  proper integration 
of in silico data with in vivo and in vitro data for design of new chemical entities, vaccines etc. 
Moreover, the design and implementation of IT in drug discovery must match well with the 
development of new scientific methods, algorithms for managing large amounts of sequence and 
structural data. This IT workflow should complement well with the different scientific programs 
involved in genome informatics, structural bioinformatics and chemoinformatics suites. 
Following important points are presented in Fig. 1, which should be taken into consideration in 
the drug discovery program. 
 Primary structure (sequence) of a medically important protein (target). 
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 Structural bioinformatics: Modeled structure of the target protein  or Structural molecular 
biology of the target protein (protein crystallography). 
 
Fig. 1: Schematic outline of the application of  SB and its integration with XML in drug 
discovery process. 
 Virtual screening or quantitative structure activity relationship (QSAR) study of  drug 
like compounds to probe the active sites of protein and its mechanism of action. 
 
 High throughput docking analysis of most active (in silico) drug like compounds. 
 
 Experimental confirmation of docking analysis (docked compounds) using X-ray 
crystallography. NMR, Kinetic experiments- binding affinity of docked compounds to 
target protein.  
 
 Prediction of  selective potent drug like compounds. ADMET predictions, drug-drug 
interactions, in vitro test assay of the designed compounds. Pharmacological testing in 
animal models. 
 
 Clinical trials and US Food and Drug Administration (FDA) approval of  novel 
compounds identified as drug. 
 
Nowdays, in structural genomics, XML representation of  sequence and structure is developing, 
to accelerate the data representation, storage, retrieval and exchange through internet, and is 
presented in Table 1. Main challenging and interesting task is to deal with this diverse set of data 
SB & Drug Discovery
XML 
Target protein sequence 
Homology modeling of  target protein 
PDBML 
Virtual library of compounds or QSAR analysis 
Large scale Docking 
Lead identification &  Lead optimization 
Confirm using experiments (Crystallography, NMR, 
Kinetic analysis etc. 
Compound development (Drug) 
 WWMM, CML, 
ToxML  (XSLT, 
SVG, STM ML,  
  UML) 
Experimental structure of target protein (Protein Data Bank)   NCBI-XML, XEMBL, CaBIO, BioML, BioPAX, CellML, SBML, PEML, 
UniProt XML, MAGE-ML, BSML, 
AGAVE, CORBA, DAS, GO-DTD, 
XFF, XUL, GAME, BIOML, SOAP 
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generated from genome to drug. The key to bioinformatics, chemoinformatics and 
pharmacoinformatics field is to accelerate discovery and solve critical problems in drug  
Table 1: XML formats, DTDs and Schemas prominently used in bioinformatics, 
chemoinformatics and pharmacoinformatics domain.  
Name URL 
AGAVE: Architecture for Genomic 
Annotation Visualization and exchange 
http://www.agavexml.org/ 
BioML: BIOpolymer Markup Language http://proteometrics.com/BIOML/ 
BioPAX: Biological Pathways Exchange http://www.biopax.org 
BSML: Bioinformatic Sequence Markup 
Language 
http://www.bsml.org 
CellML  http://www.cellml.org 
DAS: Distributed Annotation System http://www.biodas.org 
Gene Ontology (GO) DTD http://www.geneontology.org/xml-
dtd/go.dtd 
MAGE-ML: MicroArray Gene Expression 
Markup Language 
http://www.mged.org/mage 
NCBI DTDs: Numerous DTDs, including 
GBSeq, TinySeq, and NCBI Blast  
http://www.ncbi.nlm.nih.gov/dtd 
CML: Chemical Markup Language http://xml.coverpages.org/cml.html  
PSI-MI: Proteomics Standards Initiative 
Molecular Interaction 
http://www.psidev.info/ 
SBML: The System Biology Markup 
Language 
http://www.sbw-sbml.org/  
UniProt XML http://www.pir.uniprot.org/ 
 
development  by representing and integrating these tsunami data sets using semantic web 
approach based on XML. In the end, this world wide semantic web applications enables 
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individual researchers, software engineers, database managers, to easily exchange and share their 
relevant and aggregate data from multiple sources as well as mine this data for making important 
scientific clues [1-6]. 
National Center for Biotechnology Information (NCBI) and European Bioinformatics Institute 
(EBI) provide world-wide free public services by developing, organizing, networking and 
distributing different scientific databases. Main classification of these databases are, nucleotide 
databases, protein databases, structure databases, proteome databases, microarray databases, and 
literature databases etc. Various bioinformatics toolboxes for protein function analysis, 
proteomic analysis, sequence analysis, structure analysis, similarity and homology modeling  etc. 
are incorporated by appropriate submission facilities for sequence, structure and other biological 
data. In short, NCBI and EBI mainly serve as an important platform in performing structural 
bioinformatics work.  
XML for Structural Bioinformatics: 
Structural bioinformatics (SB) devotes mainly to answer questions about molecular way of life 
by using computational resources. One of the main goals of SB community is to create intelligent  
database systems and  associated softwares which is capable of storing, retrieving, analyzing and 
exchanging large sets of genomic and structural data. An exponential growth in biological 
databases is challenging to SB community for interrelating and sharing data for open scientific 
exchange. This bottleneck is overcome by the proper  usage of XML for data representation and 
its exchange over the internet. XML is officially specified by the World Wide Web Consortium 
(W3C), started in 1996, and is open standard, independent of computer operating systems and 
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File system
XML 
processor
HTTP 
processor 
<HTML> <XML> 
Database
Web server 
 
 
 
 
 
 
Fig. 2: Backbone representation of XML schema 
 programming languages. The application of XML in bioinformatics is essential to bridge the 
gap, such as, (i) No standard nomenclature exists for genomics, proteomics, chemoinformatics 
and other biological data, (ii) No standard data format exists to exchange biological data, (iii) No 
standard data model exists, and (iv) Difficulties in using and exchanging data. 
 
XML is highly flexible, internet-oriented and has very rich capabilities for linking databases 
represented in simplest form in Fig. 2. XML and document type definition (DTD) files are 
human readable and can be easily edited by people with only few computer skills. XML provides 
an open framework for defining standard specifications, because SB clearly lacks 
standardization. This language is being extensively used nowadays to manage documents and 
informations such as in macromolecular sequence,  macromolecular structure, spectra, organic 
molecules, crystallography, quantum chemistry, hypertext (HTML), databases, regulatory 
processes, molecular databases, publishing and many others. Development of protein data bank 
in XML format (PDBML) is good example in this direction [7]. All of the released PDB entries 
are now available in PDBML/XML format.  Some other well known bioinformatics contents 
such as NCBI-XML, XEMBL contribute its application at genome level (Tables 1 and 2).  
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Table 2: Some of the well known Bioinformatics/ Chemoinformatics/ Toxicoinformatics 
databases/languages in XML 
XML Databases/ 
Languages 
Importance URL 
PDB/PDBML 
(Macromolecular 
Structure database 
in XML) 
The Protein Data Bank Markup 
Language (PDBML) provides a 
representation of archival 
macromolecular structure data in 
XML format.  
http://pdbml.rcsb.org/ 
EMBL/XEMBL 
(Bioinformatics  
database in BSML 
and AGAVE) 
XEMBL has been a service to display 
data from the EMBL Nucleotide 
Sequence Database in XML formats, 
BSML (Bioinformatics Sequence 
Markup Language) and AGAVE 
(Architecture for Genomic 
Annotation, Visualization and 
Exchange) developed by Double 
Twist. for managing, visualizing and 
sharing annotations of genomic 
sequences. 
http://www.ebi.ac.uk/xem
bl/index.html 
 
http://www.bsml.org 
 
 
http://www.agavexml.org/ 
 
caBIO 
(Bioinformatics  
cancer database) 
The cancer Bioinformatics 
Infrastructure Objects (caBIO) model 
is an open source project and  all  
caBIO objects can be transformed into 
XML, and XSL/XSLT is used to 
present data in documents, web pages 
or other interfaces. 
http://ncicb.nci.nih.gov/N
CICB/infrastructure/cacor
e_overview/caBIO 
NCBI-XML 
 
(Bioinformatics  
NCBI software tools can now 
automatically produce data as XML. 
This provides developers access to the 
http://www.ncbi.nlm.nih.g
ov/IEB/ToolBox/XML/ 
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database in XML) full internal NCBI data set using a 
variety of Open Source tools.  
CML 
(Chemoinformatics  
database in XML) 
Chemical Markup Language (CML) 
An  approach for representing  
chemical structures in XML format.  
http://xml.coverpages.org/
cml.html 
ToxML 
(Toxicoinformatics  
database in XML) 
ToxML is an XML database system 
developed for toxicology information. 
https://www.leadscope.co
m/toxml.php 
 
XML for Chemoinformatics 
 
Development of XML in chemoinformatics i.e. Chemical Markup Language (CML) is another 
approach to manage molecular data. CML files are extensible in that new concepts can be added 
through its unique dictionary-based system. Namespaces allow many different disciplines to be 
combined, such as graphics, mathematics, biology, text etc. CML supports and interfaces with 
developments such as Java, C++ and Corba. CML has support for atom- and bond-based 
stereochemistry. CML can hold 2-D molecular information in a variety of ways: a) Connection 
tables, b) SMILES and c) 2-D coordinates. CML can hold 3-D molecular information in a variety 
of ways: a) 3-D Cartesian coordinates, b) fractional coordinates, c) Z-matrix, d) crystallographic 
unit cell, e) molecular symmetry and f) space group symmetry. Jumbo- an XML browser is 
designed to work with CML and XML. Jumbo browser can display XML style sheets and can 
use CML to draw molecules [8,9].  
 
Chemical coordinates of molecules in 2D and 3D represented in CML  can be visualized 
graphically using  Scalable Vector Graphics (SVG), a text-based graphics language describing 
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images with vector shapes, text, and embedded raster graphics. SVG files are compact and 
provide high-quality graphics on the web, in print, and on resource-limited handheld devices. In 
addition, SVG supports scripting and animation, so is ideal for interactive, data-driven, 
personalized graphics. The molecular data is originally stored in CML, then an EXtensible 
Stylesheet Language Transformations (XSLT) document automatically converts each CML file 
to an SVG file.  
 
World Wide Molecular Matrix (WWMM) is a molecular repository that  manages chemical 
information of molecules entirely in XML and CML/ or CCML (computational chemical markup 
language) [10]. WWMM Wiki - an online database for molecular informatics, can edit it at any 
time, from anywhere. Its main application is turning the web into a chemical knowledge base, 
getting robots to do routine tasks automating CCML,  Chemistry software toolkit development 
and research, chemical databases (design and implementation), peer-to-peer (“Napster”) 
Chemistry, GRID and eScience  technologies.  
  
WWMM enable scientists and chemists to publish at source, and provide them with a mechanism 
that ensures their molecular data is freely available for everyone around the globe. The open-
source nature of the matrix technology guarantees accessibility of scientific data for the 
community. Currently there aren't any mechanisms that would allow to globally store molecular 
data along with measured, calculated or computed properties. The WWMM only holds XML 
data, but converters to and from many common formats are provided. The matrix toolkit is able 
to convert the most common molecular file formats such as MOL/SMILES and PDB for 
submission to the WWMM.  This group also generated IUPAC International Chemical Identifier 
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(InChIs) for 250,000 molecules from the NCI database and around 10,000 molecules from the 
KEGG database respectively. These solutions reduce the high costs of research and accelerate 
revenue by using intelligent documents to transform manual, paper-based processes into 
automated digital workflows. Further, it will support in silico prediction of molecular and 
reaction properties for use in pharmaceutical design, enzymatic, clinical and  toxicological 
processes.  
 
XML for Toxicoinformatics 
 
The ability to accurately predict toxicity using quantitative structure-activity relationships 
(QSAR) is becoming more important as toxicoinformatician worldwide incorporate QSAR-based 
evaluations for hazard identification and risk assessment in safety purposes. Several practical and 
fundamental challenges need to be tackled in building reliable QSAR models, one being access 
to high-quality data from which accurate predictive models can be derived. In this regard, FDA 
has been actively collaborating with the public toxicity database standardization effort, ToxML, 
to create a set of controlled vocabulary to represent toxicity data (Table 2). Through a 
cooperative research and development agreement involving the Center for Food Safety and 
Applied Nutrition and the Center for Drug Evaluation and Research, FDA scientists now have 
access to data in consolidated databases which can be more easily incorporated into the review 
process. These databases will greatly expand safety analysis by utilizing analog information and 
improve efficiency by electronic retrieval. Currently, studies are added to these databases in a 
separate process following the safety evaluation of the submission. This method is problematic in 
that it duplicates effort and creates a lag-time between completion of the review and addition of 
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the data to the QSAR training set. In an effort to resolve this issue, FDA scientists are exploring 
reviewing submissions with real-time data entry in an effort to expand these databases. So in 
silico toxicology databases for various endpoints  need to be properly integrated and XML (i.e. 
ToxML) should play an important role in organizing and managing this data. 
Recent trend is an integrated in silico with in vitro and in vivo approaches to early ADME/T 
screening, for making effective decisions on lead molecule selection, which will help support 
and accelerate drug discovery projects. So an integrated in silico, in vitro and in vivo toxicology 
data need to be properly integrated and XML should play an important role in organizing and 
managing this drug discovery process. In addition to improving safety evaluations at the FDA, 
these databases will increase the global knowledge base and expand the scope of predictive 
toxicology.  
 
 
CONCLUSIONS AND FUTURE PROSPECTIVES 
 
The inspiration to write this article came by teaching M.S. (Pharm.) Pharmacoinformatics 
students at NIPER. This article serves as a comprehensive collection of biomedical informatics, 
where XML and semantic web is used with scientific intuition. The usage of XML for structural 
biologists, bioinformatician, chemoinformatician, toxicoinformatician and other allied fields is 
touched upon with clarity and its importance towards drug discovery program is highlighted. The 
challenging path of “bench to bedside” in the drug discovery program was considered, and the 
flow of XML along with the semantic web, for the proper integration of this tsunami data  set of  
in silico to in vivo and in vitro is appreciated and directed towards its proper usage.  
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